KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Asset Utilization Ratio: 2018-2024

Historic Asset Utilization Ratio for Aquestive Therapeutics (AQST) over the last 7 years, with Dec 2024 value amounting to 0.01.

  • Aquestive Therapeutics' Asset Utilization Ratio fell 119.76% to -0.10 in Q3 2025 from the same period last year, while for Sep 2025 it was -0.10, marking a year-over-year decrease of 119.76%. This contributed to the annual value of 0.01 for FY2024, which is 98.56% down from last year.
  • Latest data reveals that Aquestive Therapeutics reported Asset Utilization Ratio of 0.01 as of FY2024, which was down 98.56% from 0.88 recorded in FY2023.
  • Over the past 5 years, Aquestive Therapeutics' Asset Utilization Ratio peaked at 0.88 during FY2023, and registered a low of 0.01 during FY2024.
  • Its 3-year average for Asset Utilization Ratio is 0.57, with a median of 0.80 in 2022.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first spiked by 1,338.57% in 2021, then tumbled by 98.56% in 2024.
  • Yearly analysis of 5 years shows Aquestive Therapeutics' Asset Utilization Ratio stood at 0.06 in 2020, then spiked by 1,338.57% to 0.81 in 2021, then fell by 1.62% to 0.80 in 2022, then rose by 10.33% to 0.88 in 2023, then crashed by 98.56% to 0.01 in 2024.